| Chair | Jesse Roman, MD, ATSF | Philadelphia, PA |
| Committee Member | Irina Petrache, MD, ATSF | Denver, CO |
| Committee Member | Raed A. Dweik, MD, ATSF | Cleveland, OH |
| Staff | Patricia C. Huie | New York, NY |
| Staff | Karen J. Collishaw | New York, NY |
Finance Committee
The Finance Committee has responsibility for providing oversight for the overall fiscal policies and financial operations of the Society and financial reporting processes that maintain the integrity of the Society’s financial statements. It fulfills its charge by reviewing requested financial reports to ensure sound fiscal practices and the financial integrity of the Society. It reviews the Society’s investment portfolio performance, investment policy and cash management program, and reviews staff recommendations to the Board regarding the selection of investment advisors or audit firms. The Committee annually reviews and recommends to the Board an annual budget for the Society and reviews the audit report and presents its findings to the Board of Directors. It reviews all material written communication from the auditors, proposes to the Board solutions for any matters that may be noted as a result of the audit, and periodically reviews the employee benefits plans of the Society.
Benchmarks, 2023-2024:
• Participate with senior management in evaluating and recommending pathways to achieving financial sustainability for the Society. Consider new or enhanced sources of revenue, prioritization of core activities, and improved operating efficiencies as elements of a sustainable financial plan.
• Review and recommend to the Board an ATS annual budget that maintains the fiscal integrity of the Society.
• Work with ATS Chief Financial Officer and finance staff to enhance financial reporting to the ATS Executive Committee and Board of Directors;
• Review draft audited financial statements and present auditors’ findings and recommendations to the Board of Directors;
• Review and present to the Board the compensation subcommittee’s recommendations for 2023 and 2024 volunteer and leader compensation levels and the treatment of any compensation issues;
• Interact with and review performance of new investment portfolio advisors.
• Nominate a diverse slate of candidates for ATS Respiratory Health Awards.
